Life Technologies Sets 1st Quarter 2011 Earnings Release Date for Tuesday, Apri... ( CARLSBAD Calif. April 5 2011 /- Life ...)

Life Technologies Sets 1st Quarter 2011 Earnings Release Date for Tuesday, April 26, 2011

Date:4/5/2011

CARLSBAD, Calif., April 5, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its first quarter 2011 financial results on Tuesday, April 26, 2011, after market close. The company will also hold a webcast on the same day at 4:30 p.m. ET to discuss operating results, as well as future expectations.

(Logo: https://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

The webcast can be accessed through the investor relations page of the Life Technologies website at ir.lifetechnologies.com/events.cfm. A replay of the webcast will be available on the Company's website through Tuesday, May 17, 2011.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group

Post Your Comments:

(Date:6/20/2013)... (PRWEB) June 20, 2013 Conscires offer ... levels of interests and budgets., , ... on Scrum basics and the ScrumMaster role. In addition ... group activities and discussions on the necessary soft skills ... Scrum Team, and company-oriented Scrum implementation aspects. , ...

(Date:6/19/2013)... , June 19, 2013 U.S. Secretary of State ... at which distinguished Syngenta scientist Mary-Dell Chilton ... 2013 World Food Prize. The prize is the foremost ... by improving the quality, quantity or availability of food ... other laureates were recognized for "revolutionary biotechnology discoveries that ...

(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...

Breaking Biology Technology:Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices 2 Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2 Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2 Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3

[0] Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices [0] Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate [0] Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System [0] Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

... ST. LOUIS, Oct. 5 ISTO Technologies, Inc. (ISTO), ... regeneration, announced today the completion of patient enrollment in ... an injectable formulation of juvenile chondrocytes designed for the ... patients enrolled at two clinical sites. All patients enrolled ...

... Lake, N.Y. Given the many pressing concerns of the ... to lose sleep. But for those whose responsibility it is ... charged with that mission include scientists like medical researcher Steve ... develop a vaccine that will protect the public against weaponized ...

... (Nasdaq: AMGN ) today announced that results ... trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX ... metastatic colorectal cancer (mCRC), respectively, were published online in ... "Both studies demonstrated that Vectibix administered with chemotherapy ...

ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial Plague researchers race to beat bioterrorists Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology

(Date:6/19/2013)... In the cover story for the journal ... at the University of Massachusetts Amherst describe a new ... study the function of individual proteins in individual cell ... should allow deeper insights into protein function, Chase says, ... what that single protein does when we isolate its ...

(Date:6/19/2013)... International Science Consortium (PISC) is extremely disappointed that ... has upheld a decision that requires Dow Benelux ... rats. The study will use approximately 1160 animals ... to the substance dipropylene glycol methyl ether acetate ... Community,s Regulation on the Registration, Evaluation, Authorisation and ...

(Date:6/19/2013)... Diversity Course at the Marine Biological Laboratory (MBL), ... in Microbiology site by the American Society for ... program recognizes institutions and the scientists who worked ... the science of microbiology. A ceremony unveiling ... scheduled for Saturday, June 22, 2013, at 4:30 ...

Breaking Biology News(10 mins):UMass Amherst researchers develop powerful new technique to study protein function 2 UMass Amherst researchers develop powerful new technique to study protein function 3 Microbial diversity course designated as a 'Milestones in Microbiology' site 2

[0] UMass Amherst researchers develop powerful new technique to study protein function [0] PETA International Science Consortium disappointed in denial of Dow appeal [0] Microbial diversity course designated as a 'Milestones in Microbiology' site

... Nov. 17, 2011 Life Technologies Corporation ... that the company has introduced its GeneArt® Algae ... and expression systems for photosynthetic microalgae Chlamydomonas ... strains are model organisms for the study of ...

... -- Researchers have demonstrated that the employees at ... fruits and vegetables and get 50 percent more exercise ... participating in the WellSteps Turnkey Wellness Solution ... and sleep quality. Employees also demonstrated fewer hospital and ...

... might be considered a "performance enhancing" substance for athletes, ... Journal ( http://www.fasebj.org ) shows that these enhancements ... in the brain. According to the study, short- ... constricting arteries, which reduces the flow of blood to ...

Cached Biology News:GeneArt® Algae Engineering Kits by Life Technologies™ 2 GeneArt® Algae Engineering Kits by Life Technologies™ 3 New Study Shows Impact of Employee Wellness Efforts 2 Biker's warning! EPO hits blood vessels to raise blood pressure in the brain 2

GeneArt® Algae Engineering Kits by Life Technologies™New Study Shows Impact of Employee Wellness Efforts Biker's warning! EPO hits blood vessels to raise blood pressure in the brain

... Goat Immunogen: Goats were ... Antibody was isolated by affinity chromatography ... Goat anti- human T7 affinity purified antibodies ... bromide method. Specificity: ...

Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....

Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...

LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...

Biology Products:

Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex Anti-Varicella-zoster Virus, Nucleocapsid Protein Monoclonal Antibody, Unconjugated from CHEMICON Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from Abcam Anti-Echovirus LIGHT DIAGNOSTICS Antibody, Unconjugated from CHEMICON